NEW YORK, November 2, 2016 – Reed Smith LLP represented Citron Pharma LLC, a privately held pharmaceutical company focused on developing and marketing generic products from diverse therapy segments, and its affiliate Lucid Pharma LLC, in the acquisition of their generic drug-related assets by ACETO Corporation (NASDAQ:ACET).  ACETO is an international company engaged in the development, marketing, sale and distribution of human health products, pharmaceutical ingredients and performance chemicals.  The deal was valued at approximately $412 million.

The Reed Smith team, co-led by New York partner Niket Rele and Pittsburgh partner Courtney C. Murray, included Pittsburgh associate John Algie.  Additional support was provided by New York partner James R. Tandler‎, Chicago partner Benjamin L. Brimeyer, and New York associate Brent C. Vegliacich.

Read ACETO Corporation’s press release at